Zimmer Biomet said today that the FDA closed out a 2015 warning letter over problems at a subsidiary’s plant in China.
The June 3, 2015 letter flagged 5 violations found during inspections of the Zhejiang Biomet Medical Products plant in Jinhua City, Zhejiang, following inspections of January of that year.
The federal safety watchdog closed the matter May 8.
